Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder
Open-Label Study of Concerta in the Treatment of ADHD in Youth and Adults With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder
Sponsor: Massachusetts General Hospital
A PHASE4 clinical study on ADHD and Bipolar Disorder, this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 7 data snapshots since 2002. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
7 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Aug 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .